Vuori Kristiina MD
- SEC CIK
- 0001612627
No open-market purchases or sales filed in the past year.
Current role at each company
- INBX Inhibrx Biosciences, Inc.Directoras of Sep 18, 2026
- FORA Forian Inc.Directoras of May 15, 2026
- BNGO Bionano Genomics, Inc.Directoras of May 14, 2026
- Inhibrx, Inc.Directoras of May 30, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Vuori Kristiina MD as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
INBX Inhibrx Biosciences, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2024 (view filing) | Aug 29 | 5 days | Vuori Kristiina MDDirector | PPurchase | +7.14K | $14.00 | +$100.0K | New position7.14K after | |
| Sep 12, 2024 (view filing) | Sep 10-11 | 2 days | Vuori Kristiina MDDirector | PPurchase | +6.64K | $15.07 | +$100.0K | +92.9%13.8K after | 2 lots |
| Oct 7, 2024 (view filing) | Oct 3 | 4 days | Vuori Kristiina MDDirector | PPurchase | +6.67K | $15.00 | +$100.0K | +48.4%20.4K after |